Sunhawk Vision Biotech (ROCO:7759) ROC (Joel Greenblatt) %: -825.61% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7759 Sunhawk Vision Biotech Inc ROCO:7759
10 GF Score
Price NT$28.60
! 1 Warning Sign
View Full Analysis

What is Sunhawk Vision Biotech ROC (Joel Greenblatt) %?

Sunhawk Vision Biotech ROCO:7759 -4.67% 10 ROC (Joel Greenblatt) % is -825.61% as of Dec. 2025. GuruFocus rates ROCO:7759 with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 1,324 Biotechnology companies, Sunhawk Vision Biotech ranks worse than 63.44% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sunhawk Vision Biotech's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -825.61%.

The historical rank and industry rank for Sunhawk Vision Biotech's ROC (Joel Greenblatt) % or its related term are showing as below:

ROCO:7759' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -857.58   Med: -754.22   Max: -213.97
Current: -746.91

During the past 6 years, Sunhawk Vision Biotech's highest ROC (Joel Greenblatt) % was -213.97%. The lowest was -857.58%. And the median was -754.22%.

ROCO:7759's ROC (Joel Greenblatt) % is ranked worse than
63.44% of 1324 companies
in the Biotechnology industry
Industry Median: -306.72 vs ROCO:7759: -746.91

Sunhawk Vision Biotech's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Sunhawk Vision Biotech  (ROCO:7759) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Sunhawk Vision Biotech ROC (Joel Greenblatt) % Related Terms


Sunhawk Vision Biotech ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Sunhawk Vision Biotech's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunhawk Vision Biotech ROC (Joel Greenblatt) % Chart

Sunhawk Vision Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial -754.22 -213.97 -762.88 -379.57 -857.58

Sunhawk Vision Biotech Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only -1,003.73 -126.55 -338.55 -625.11 -825.61

ROCO:7759 vs VRTX, REGN, RVMD: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, Sunhawk Vision Biotech's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunhawk Vision Biotech ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Sunhawk Vision Biotech's ROC (Joel Greenblatt) % falls into.


ROCO:7759
10GF Score
Sunhawk Vision Biotech Inc ROCO:7759
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunhawk Vision Biotech ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 35.138) - (17.261 + 0 + 0)
=17.877

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 17.982) - (21.279 + 0 + 0)
=-3.297

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Sunhawk Vision Biotech for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-154.678/( ( (11.13 + max(17.877, 0)) + (8.463 + max(-3.297, 0)) )/ 2 )
=-154.678/( ( 29.007 + 8.463 )/ 2 )
=-154.678/18.735
=-825.61 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -825.61% mean?
Sunhawk Vision Biotech (ROCO:7759) has a ROC (Joel Greenblatt) % of -825.61% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sunhawk Vision Biotech and its competitors. According to the industry distribution chart, Sunhawk Vision Biotech ranks #840 out of 1324 companies in the Biotechnology industry, placing it in the top 63.4%.
Is Sunhawk Vision Biotech's ROC (Joel Greenblatt) % too high?
Sunhawk Vision Biotech's current ROC (Joel Greenblatt) % is -825.61%. Based on the distribution chart, Sunhawk Vision Biotech ranks #840 out of 1324 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sunhawk Vision Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's ROC (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunhawk Vision Biotech ranks #840 out of 1324 companies for ROC (Joel Greenblatt) %. This places Sunhawk Vision Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sunhawk Vision Biotech and its competitors. Sunhawk Vision Biotech's current ROC (Joel Greenblatt) % is -825.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current ROC (Joel Greenblatt) % of -825.61%. The current ROC (Joel Greenblatt) % is -825.61%. Sunhawk Vision Biotech's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current ROC (Joel Greenblatt) % is -825.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunhawk Vision Biotech Business Description

Address No. 6 Siwei 3rd Road, 17th Floor, Room A1, Lingya District, Kaohsiung, TWN
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
10GF Score

Get the complete analysis for ROCO:7759

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.60
Price